Bionano Genomics, Inc.
BNGO
$0.7611
-$0.0333-4.19%
| Weiss Ratings | BNGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | BNGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | BNGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 2.35 | |||
| Price History | BNGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -19.47% | |||
| 30-Day Total Return | -29.08% | |||
| 60-Day Total Return | -35.48% | |||
| 90-Day Total Return | -45.33% | |||
| Year to Date Total Return | -60.64% | |||
| 1-Year Total Return | -89.89% | |||
| 2-Year Total Return | -95.65% | |||
| 3-Year Total Return | -98.72% | |||
| 5-Year Total Return | -98.11% | |||
| 52-Week High % Change | -90.72% | |||
| 52-Week Low % Change | 6.48% | |||
| Price | BNGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $8.20 | |||
| 52-Week Low Price | $0.71 | |||
| 52-Week Low Price (Date) | Apr 18, 2024 | |||
| 52-Week High Price (Date) | Jun 05, 2023 | |||
| Valuation | BNGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 45.92M | |||
| Enterprise Value | 58.57M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -6.78 | |||
| Earnings Per Share Growth | 48.14% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.83 | |||
| Price/Book (Q) | 0.36 | |||
| Enterprise Value/Revenue (TTM) | 1.64 | |||
| Price | $0.79 | |||
| Enterprise Value/EBITDA (TTM) | -0.46 | |||
| Enterprise Value/EBIT | -0.42 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | BNGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 39.86M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | BNGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 858 888 7600 | |||
| Address | 9540 Towne Centre Drive San Diego, CA 92121 | |||
| Website | www.bionano.com | |||
| Country | United States | |||
| Year Founded | 2003 | |||
| Profitability | BNGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -393.05% | |||
| Profit Margin | -643.73% | |||
| Management Effectiveness | BNGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -34.00% | |||
| Return on Equity | -- | |||
| Income Statement | BNGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 36.12M | |||
| Total Revenue (TTM) | 36.12M | |||
| Revenue Per Share | $0.91 | |||
| Gross Profit (TTM) | 9.57M | |||
| EBITDA (TTM) | -128.25M | |||
| EBIT (TTM) | -141.96M | |||
| Net Income (TTM) | -232.49M | |||
| Net Income Avl. to Common (TTM) | -232.49M | |||
| Total Revenue Growth (Q YOY) | 30.51% | |||
| Earnings Growth (Q YOY) | -13.48% | |||
| EPS Diluted (TTM) | -6.78 | |||
| EPS Diluted Growth (Q YOY) | 15.33% | |||
| Balance Sheet | BNGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 66.77M | |||
| Cash Per Share (Q) | $1.68 | |||
| Total Current Assets (Q) | 140.12M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 96.16M | |||
| Current Ratio (Q) | 1.401 | |||
| Book Value Per Share (Q) | $2.10 | |||
| Total Assets (Q) | 214.40M | |||
| Total Current Liabilities (Q) | 100.03M | |||
| Total Debt (Q) | 79.41M | |||
| Total Liabilities (Q) | 118.25M | |||
| Total Common Equity (Q) | 96.16M | |||
| Cash Flow | BNGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 24.16M | |||
| Cash from Financing (TTM) | 113.82M | |||
| Net Change in Cash (TTM) | 12.86M | |||
| Levered Free Cash Flow (TTM) | -99.31M | |||
| Cash from Operations (TTM) | -125.18M | |||
